Skip to main content
. 2022 Aug 26;323(4):H749–H762. doi: 10.1152/ajpheart.00311.2022

Figure 8.

Figure 8.

Effects of aging and SVF therapy on mitochondrial function and vasodilation. Illustration summarizes RNA sequencing data, and isolated vessel experimental results in the context of the ETC/oxidative phosphorylation, mitochondrial fission, fusion, mitophagy, and antioxidant/prooxidant enzyme balance and their influences on β1AR-mediated and flow-mediated dilation. Genes were included with significance as P < 0.1. Green arrow indicates activating whereas red line indicates inhibitory action. Note, antioxidant/prooxidant enzyme list and contributions of ROS/NO on β1AR and FMD summarize results from our preceding study (9). Image created with BioRender.com and published with permission. ROS, reactive oxygen species; SVF, stromal vascular fraction.